Haleema Shakur-Still | |
---|---|
Known for | Research on tranexamic acid |
Academic work | |
Discipline | Global health |
Sub-discipline | Clinical trials |
Institutions | London School of Hygiene & Tropical Medicine |
Haleema Shakur-Still is a professor of Global Health Clinical Trials and the co-director of London School of Hygiene & Tropical Medicine's Clinical Trials Unit. [1]
Shakur-Still has worked in global health clinical trials for over 16 years, specifically focusing on emergency care. [2] Shakur-Still's work includes designing and conducting clinical trials, as well as developing ways to communicate the work to clinicians, policy makers, and the public.
Shakur-Still ran the WOMAN Trial which looked the blood clot stabilising drug tranexamic acid for post-delivery bleeding, which is the largest cause of maternal mortality around the world. This trial involved over 20,000 patients from 21 countries. [3] [4] [5]
In 2017 the World Health Organization updated their guidance from 2012 to recommend the use of tranexamic acid within three hours of birth when postpartum haemorrhage is diagnosed. [6] [7]
In February 2018 the WOMAN project was the third winner of the European Commission's Horizon Birth Day Prize, and was awarded a €500,000 prize by the MSD for Mothers. [8]